Not a good buy right now for an impatient trader: the setup is technically strong but stretched (RSI elevated) and sitting just below near-term resistance, with weak fundamental/credit optics and heavy hedge-fund selling.
Upside to the main Street targets ($23–$25) exists but is relatively limited vs. the near-term downside risk if price rejects resistance (~$22.43–$22.96) and fades back toward the ~$21.55 pivot.
With no Intellectia buy signals today and no news catalyst, this looks more like a “don’t chase” moment than an immediate entry.
Profitability: Net income 2.70M, -84.00% YoY; EPS 0.07, -82.50% YoY (sharp earnings deterioration despite revenue growth).
Takeaway: Growth in revenue is being overwhelmed by profitability/credit-related pressure—fundamentals do not support chasing an extended rally right here.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent direction: Price targets have been raised across multiple firms (KBW $21→$23; Piper $22→$25; Raymond James $21→$23), indicating improving confidence in risk/reward after updates/transition.
Ratings mix: Overweight/Outperform (Piper, Raymond James) vs Market Perform (KBW) highlights a split Street view.
Wall Street pros: Better risk-reward after management/transition efforts; targets imply some upside.
Wall Street cons: Ongoing credit deterioration (NPL/classified loan migration) and non-GAAP charges; earnings power remains pressured.
Influential trading: No recent congress trading data; insiders neutral with no significant recent trend.
Wall Street analysts forecast AMTB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMTB is 21.67 USD with a low forecast of 20 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast AMTB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMTB is 21.67 USD with a low forecast of 20 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 22.990
Low
20
Averages
21.67
High
23
Current: 22.990
Low
20
Averages
21.67
High
23
Keefe Bruyette
Market Perform
maintain
$21 -> $23
AI Analysis
2026-01-28
Reason
Keefe Bruyette
Price Target
$21 -> $23
AI Analysis
2026-01-28
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Amerant Bancorp to $23 from $21 and keeps a Market Perform rating on the shares.
Piper Sandler
Overweight
maintain
$22 -> $25
2026-01-26
Reason
Piper Sandler
Price Target
$22 -> $25
2026-01-26
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Amerant Bancorp to $25 from $22 and keeps an Overweight rating on the shares. The firm notes a spike in NPLs and several non-GAAP charges impeded Q4 2025 results. The hope is that these steps backward allow the bank to finally move consistently forwards, and past what has been a very bumpy path over the last few years, Piper adds.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AMTB
